Table 3. GEE analysis of factors related to total expenditures during treatment for MassHealth members who received treatment for opioid addiction between 2003 - 2010.
| Factor | Estimate | (95% CI) |
|---|---|---|
| Intercept | 384.20 | (320.06, 448.34)*** |
| Age | 3.89 | (2.65, 5.13)*** |
| Gender (male = 1) | 3.69 | (-19.31, 26.68) |
| CDPS | 179.10 | (162.96, 195.24)*** |
| Expenditures during the 6 months before the episode | 0.30 | (0.25, 0.36) *** |
| Co-occurring mental illness | ||
| Severe mental illness | 332.06 | (291.33, 372.79)*** |
| Other mental illness | -16.31 | (-43.02, 10.40) |
| Major depression | -9.75 | (-44.33, 24.84) |
| Co-occurring substance abuse disorder | ||
| Alcohol | 437.41 | (384.22, 490.60)*** |
| Other drug | 140.60 | (110.75, 170.44) *** |
| Type of current episode (compared to non-OAT behavioral health treatment) | ||
| Buprenorphine | -190.88 | (-222.71, -159.04)*** |
| Methadone | -183.64 | (-213.87, -153.41)*** |
| Number of prior buprenorphine treatment episodes | -58.82 | (-87.24, -30.39)*** |
| Number of prior methadone treatment episodes | -87.27 | (-116.24, -58.30)*** |
| Number of prior treatment episodes without OAT | -31.01 | (-55.63, -6.38)* |
*
p < .05
***
p < .0001